Compliance Challenges in India: Why Your Program May Not Translate: Part 2
September 9, 2016
Partner David Simon was featured in a Compliance & Ethics article, “Compliance Challenges in India: Why Your Program May Not Translate: Part 2.” The article previewed an upcoming Compliance & Ethics Institute session, where Simon is featured as a panelist, and walked through a scenario of a company’s India market strategy involving independent sales representatives allegedly taking bribes. Simon provided insight and recommended next steps from an outside counsel perspective. He said, “I would likely recommend pulling and reviewing all related government sales contracts, conducting a forensic accounting review of the payments associated with them and conducting interviews of the sales representative himself and any involved employees in an attempt to identify inappropriate payments or improper influence.”
To read more about part 1, click here.
To read more about part 1, click here.
Author(s)
Related Insights
June 3, 2025
Foley Corporate Governance Update
Texas Senate Bill 2337: Protecting Texas Companies and Their Directors, Shareholders and Boards from Proxy Advice Not in the Financial Interests of Shareholders
On June 2, 2025, the Texas Legislature passed Senate Bill 2337, meaningfully regulating proxy advisors like ISS and Glass Lewis when providing proxy voting recommendations concerning Texas companies.
September 25, 2025
Events
Unclaimed Property Roundtable with Delaware State Escheator and Leading Practitioners
June 3, 2025
Health Care Law Today
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.